ACST

Acasti Pharma

1ACST
CAN
NASDAQ

$3.30

24H

1.79%

Market Cap

31 M

Volume

7.1 K

Supply

9.4 M

Price Chart

About Acasti Pharma - ACST

Acasti Pharma Inc. is a biopharmaceutical company that historically focused on the research, development, and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. Their flagship drug candidate was CaPre, intended for the treatment of hypertriglyceridemia, which is a condition characterized by high levels of triglycerides in the bloodstream.

What are Acasti Pharma's core values and mission statement?

Acasti Pharma Inc. is focused on developing and commercializing innovative human therapeutics, and their core mission is to harness the unique properties of omega-3 fatty acids to create drugs that address significant unmet medical needs. Their core values include a commitment to scientific excellence, integrity, and collaboration to advance the health and well-being of patients.

Who founded Acasti Pharma and when?

Acasti Pharma Inc. was founded in 2008 by the parent company Neptune Wellness Solutions.

Who leads Acasti Pharma?

As of the last update I have, Jan D'Alvise was serving as the President and Chief Executive Officer of Acasti Pharma Inc. Leadership details can change, so for the most recent information, it is best to consult the company's official website or official press releases.

Where is Acasti Pharma located, and what is its base country?

Acasti Pharma Inc. is a biopharmaceutical company headquartered in Laval, Quebec, Canada.

On which exchanges is Acasti Pharma traded?

Acasti Pharma Inc. has been listed on the NASDAQ Capital Market under the ticker symbol ACST and on the TSX Venture Exchange in Canada.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open/Close
Low/High
Volume
Cap

Acasti Pharma (ACST) Price Live Data

The live price of Acasti Pharma (ACST) is $3.30, with a trading volume of 7,094 in the last 24 hours. Wrapstocks updates the ACST price in real-time. Acasti Pharma is down -1.79% in the last 24 hours. The company has a live market cap of $31,018,020.00 and a supply of 9,399,400 ACST stocks.

Acasti Pharma (ACST) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 17 hours and 8 minutes.

Exchange
NASDAQ
NASDAQ
NASDAQ Stock Exchange
USA
Opens in
17 hours and 8 minutes
Working Hours
Mon-Fri, 01:30 PM - 08:00 PM
Timezone
GMT+0
Last Updated
16 Apr 2024 07:56 PM